￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed analysis of pacritinib’s medical insurance price, reimbursement policy and patient purchase reference

2026-02-01 22:25:32

Check Details
Letermovir tablets (Letermovir) medical insurance inclusion status, reimbursement conditions and cost reference instructions

2026-02-01 22:25:32

Check Details
Etrasimod tablets (Etrasimod)-Velsipity domestic drug purchase channels, usage and dosage, and patient usage guide analysis

2026-02-01 22:25:32

Check Details
Analysis of indications, treatment scope, clinical efficacy and usage guidelines of Rutrombopag (Wenda)

2026-02-01 22:25:32

Check Details
Detailed analysis of how to take Omarigliptin and when to take it

2026-02-01 22:25:32

Check Details
Lecanemab-LEQEMBI long-term use recommendations and analysis of discontinuation risks and safety

2026-02-01 22:25:32

Check Details
Analysis of pharmacological properties and clinical treatment principles of golodirsen

2026-02-01 22:25:32

Check Details
Disitamab’s launch time, approval progress and analysis of domestic and foreign drug purchase channels

2026-02-01 22:25:32

Check Details
Analysis of whether isatuximab (Xacoyi) is a targeted drug and its mechanism of action and clinical application principles

2026-02-01 22:25:32

Check Details
Evaluation of the efficacy of capicitinib in tumor treatment and the experience of different patients

2026-02-01 22:25:32

Check Details
Differences in indications and efficacy and comparison of clinical applications between guselkumab (Tenoya) and cosentyx

2026-02-01 22:25:32

Check Details
Tenapanor hydrochloride (tenapanor) latest price reference in 2026 and analysis of drug purchase channels and cost explanations

2026-02-01 22:25:32

Check Details
Category
相关知识